Quell® Mobile App
NeuroMetrix, Inc.
Quell’s wearable device brings drug-free relief for people suffering from chronic pain. The Quell Relief mobile app helps 10,000 users/month control their therapy and improve their pain management.
web
web
mobile
mobile
desktop
desktop
embedded


The Quell Device
The Quell wearable pain relief device from NeuroMetrix fights chronic pain by stimulating nerves in the upper calf, which send neural pulses to the brain. This causes the brain to release natural opiates that block pain signals and deliver widespread pain relief throughout the body.
Quell is a new alternative to treating chronic pain, and the first device of its kind approved by the FDA for use during sleep.
The Quell Relief App
Atomic developed the accompanying Quell Relief mobile app, which lets the user:
- Start and stop therapy sessions and adjust the intensity of therapy.
- Customize therapy (including stimulation patterns and sleep modes) to suit their pain level.
- Track and review detailed insights about therapy, sleep, pain, and activity.
It also displays the battery level and the remaining life of the device’s electrodes, and it links directly to Quell’s online store.
Quell Relief syncs with the device via Bluetooth LE. Both iOS and Android versions are available.


Coordinating Stakeholders



Technical Specs
Atomic designed the system architecture and wrote software and firmware for:



Results
- Nearly 60,000 Quell devices have been shipped to customers.
- The Quell Relief mobile app has 20,900 active users/month, accessing the app an average of 28,500 times/day.
- A study of quell’s effectiveness was included in the peer-reviewed Journal of Pain Research.
- During an Ipsos user study, 81% of Quell users reported improvement in chronic pain and overall health, and 67% of users reported a reduction in their pain medication.
Quell in the News
- 10 Wearables That Stole The Show At CES, CRN
- The Medicine-Free Pain Relieving Device, The Henry Ford’s Innovation Nation
- This Wearable Fights Chronic Pain—Without Drugs, Fast Company
- Quell hacks your brain to relieve chronic pain, CNET
- Read More Articles

Shai Gozani, M.D., Ph.D., CEO, NeuroMetrix, Inc.

Coordinating Stakeholders



A Partnership with a Storybook Ending
The team’s careful project management, client communication, cutting-edge architecture, and cohesive design strategy helped the team ship the product on time and on budget.
Reflecting back on the multi-year, high-profile project, Robinson said Atomic helped his company arrive at a special moment in time.
“We'd never done anything this big. Ever,” he said. “We’re live across all the major pillars Atomic said they would deliver on. It was delivered on time, on budget, to expectation, live. Not three or four milestones late with people leaving and the platform half-baked and full of bugs.”
StoryLoom began open-beta in December 2022. A global launch is scheduled for the spring of 2023.
“Our future is pretty bright,” said Robinson. “We’ve been given a rare opportunity to find success by chasing opportunities Starship Enterprise-style: going where people aren’t—pushing boundaries.”
Atomic provided iOS and Android mobile app development for Quell Relief using Objective-C, ReactiveCocoa, and Java. Atomic also developed the Quell Health Cloud, a server-side component that stores usage and sleep history for Quell Relief users. IDEO completed the industrial design and mechanical engineering of the Quell medical device.